Published in Women's Health Weekly, August 18th, 2005
The goal of the study was "evaluation whether Jewish founder mutations in BRCA predispose to borderline tumors as they do to early invasive ovarian cancers. All Jewish women with borderline or invasive ovarian tumors, diagnosed over a 5-year period (1994-1999), were identified in the frame of a nationwide epidemiological study on ovarian cancer in Israel," scientists reported in the journal Gynecologic Oncology.
"Out of a total of 1489 patients, 1269 were interviewed; of them 256 (20.2%)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly